Allergan Stymies Generic Glaucoma Med In Patent Trial
Allergan Inc. halted four competing drugmakers' attempts to produce generic versions of its glaucoma drug Lumigan on Monday, when a Texas federal judge ruled that their proposed products would infringe five...To view the full article, register now.
Already a subscriber? Click here to view full article